Katie Lapidus advises private and public companies of all stages on a variety of corporate matters including formation, financing activities, corporate governance and securities law compliance. Katie also represents companies and underwriters in initial public offerings and follow-on securities offerings and counsels public companies with respect to SEC reporting obligations.

Download full bio 


  • Karuna Therapeutics – $862.5 Million Follow-on Offering 

  • Allbirds – $348.3 Million IPO 

  • Acumen Pharmaceuticals – $160 Million IPO 


    True Crime



  • William & Mary Law School
    JD, summa cum laude, 2020

  • University of Virginia McIntire School of Commerce
    BS, Commerce
    with distinction, 2015

Admissions & Credentials

District of Columbia

Media & Insight